Document 2888 DOCN M94A2888 TI Treatment of AIDS and progressive multifocal leucoencephalopathy (PML) with cytarabine when the brain biopsy is unsuccessful or impossible. DT 9412 AU Ravaux I; Quinson AM; North MO; Gallais H; Infectious Diseases Unit, Hopital La Conception, Marseille,; France. SO Int Conf AIDS. 1994 Aug 7-12;10(1):201 (abstract no. PB0231). Unique Identifier : AIDSLINE ICA10/94369687 AB OBJECTIVE: Is it justified to propose a treatment with CYTARABINE IV when the diagnosis is only strongly presumed on clinical courses. CT scanner and IRM, therapeutic criteria and responsiveness to a three weeks course of antitoxoplasma therapy. OUR EXPERIENCE: We have studied 12 AIDS patients, 7 women and 5 men, from 25 to 45 years old, with CD4 count inferior to 200/mm3. 11 of them used AZT (500 mg/j). CLINICAL PRESENTATION: Headache, disorders of cognitive functions with or without focal signs. The assay of antitoxoplasma therapy failed. The white matter was affected exclusively by multiple lesions or a single large lesion: showing homogeneously hypodense areas at CT and low density (T1) or high signal intensity areas. Predominated at the cortical subcortical junction. Without diffuse and symmetrical involvement of the white matter, no mass effect. For 4 patients specific JC virus DNA amplification by PCR in CSF was used with positive results. All of them have received IV CYTARABINE HYPOCHLORIDE therapy. RESULTS: After 9 months of treatment including 6 sequences of therapy, one patient is alive and his clinical state is really ameliorated: but 5 died before 3 months, for the others, after stabilisation during 5 months, they also died of opportunistic infections. DISCUSSION: So, in front of clinical and radiological signs of PML we think that CYTARABINE IV could be proposed, even if the diagnosis is not histologically confirmed. DE Adult AIDS-Related Opportunistic Infections/DIAGNOSIS/*DRUG THERAPY Biopsy Brain/PATHOLOGY Cytarabine/*THERAPEUTIC USE Female Human Leukoencephalopathy, Progressive Multifocal/DIAGNOSIS/*DRUG THERAPY Male Middle Age MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).